🔬 scienceConcept2 views3 min read

What Happened to Kuru (disease)?

Kuru is a rare, incurable, and fatal neurodegenerative prion disease that reached epidemic proportions among the Fore people of Papua New Guinea in the mid-20th century. Transmitted through ritualistic endocannibalism, particularly the consumption of infected brain tissue, the disease has virtually disappeared since the practice ceased in the late 1950s. Kuru's study has been pivotal in understanding prion diseases and human genetic resistance, with research continuing into 2026 to inform treatments for related neurodegenerative conditions.

Share:

Quick Answer

Kuru, a fatal neurodegenerative disorder caused by infectious prions, was historically prevalent among the Fore people of Papua New Guinea due to ritualistic cannibalism. Following the cessation of this practice in the late 1950s, the disease has almost entirely vanished, with the last known death reported in 2009. Ongoing research, including studies published in 2024 and 2025, continues to analyze the genetic resistance developed by the Fore people and explore potential therapeutic strategies for prion diseases, leveraging the insights gained from Kuru to advance understanding of neurodegenerative conditions.

📊Key Facts

Peak Mortality Rate (1950s)
Up to 35 deaths per 1,000 people in affected villages
MD Searchlight, StatPearls
Total Estimated Deaths
Approximately 2,700
Wikipedia
Longest Incubation Period Recorded
Over 50 years
Wikipedia, StatPearls, MedlinePlus
Last Known Death
2009
Wikipedia, ResearchGate

📅Complete Timeline14 events

1
c. 1900Major

Possible Origin of Kuru Epidemic

The Kuru epidemic is believed to have originated around this time from a single individual in the Fore territory who developed sporadic Creutzfeldt-Jakob disease, which then spread through ritualistic cannibalism.

2
1951Major

First Official Report Using 'Kuru'

Australian officer Arthur Carey is the first to use the term 'kuru' in an official report to describe a new disease afflicting the Fore tribes, noting its prevalence among women.

3
1950sCritical

Peak of Kuru Epidemic

The Kuru epidemic reaches its peak, with mortality rates in some affected villages as high as 35 per 1,000 people, primarily impacting women and children.

4
1957Critical

Gajdusek and Zigas Publish First Major Research

D. Carleton Gajdusek and Vincent Zigas publish their seminal report in the Medical Journal of Australia, marking the beginning of intensive scientific investigation into Kuru.

5
Late 1950s/Early 1960sCritical

Cessation of Cannibalism

The Australian administration of Papua New Guinea bans ritualistic cannibalism, and the practice largely ceases among the Fore people, leading to a significant decline in Kuru transmission.

6
1976Critical

D. Carleton Gajdusek Awarded Nobel Prize

D. Carleton Gajdusek receives the Nobel Prize in Physiology or Medicine for his discoveries concerning new mechanisms for the origin and dissemination of infectious diseases, specifically his work on Kuru.

7
1982Major

Stanley Prusiner Coins 'Prion'

Stanley Prusiner introduces the term 'prion' to describe the proteinaceous infectious particles responsible for Kuru and other transmissible spongiform encephalopathies.

8
July 1996 - June 2004Major

Identification of New Cases with Long Incubation Periods

A surveillance study identifies 11 new Kuru patients, all born before the cessation of cannibalism, demonstrating incubation periods that could exceed 50 years.

9
2009Critical

Last Known Death from Kuru and Discovery of Resistance Gene

The last known death from Kuru is reported. In the same year, researchers discover a naturally occurring genetic variant (G127V) in the Fore population that confers strong resistance to Kuru.

10
June 2015Major

Publication on G127V Variant's Protective Effect

Research is published demonstrating that the G127V variant of the human prion protein completely prevents prion disease, highlighting its significance for understanding genetic resistance.

11
March 23, 2024Notable

New Genetic Analysis of Kuru Epidemic

The Guardian reports on new genetic analysis shedding light on the Kuru epidemic, including migration patterns and the evolution of resistance within the Fore population.

12
April 24, 2025Major

Prion Disease Treatment Research Milestone

New research published in Nature Medicine shows that altering a single base in the gene producing prion proteins can reduce their amount in mouse brains, extending lifespan and offering hope for future treatments for prion diseases.

13
November 3-7, 2025Notable

Prion 2025 Congress Held in Brazil

The 'Prion 2025' congress takes place in Armação dos Búzios, Brazil, bringing together scientists to discuss advancements in basic science, diagnostics, and therapeutic strategies for prion and prion-like diseases.

14
March 9, 2026Major

Ongoing Research and Significance

As of today, Kuru continues to be a crucial model for understanding prion diseases, genetic resistance, and long incubation periods, informing ongoing research into neurodegenerative disorders and potential therapies.

🔍Deep Dive Analysis

Kuru is a transmissible spongiform encephalopathy (TSE), a class of invariably fatal neurodegenerative disorders caused by abnormally folded proteins called prions. The disease gained notoriety in the mid-20th century for its epidemic spread among the Fore people and neighboring linguistic groups in the Eastern Highlands of Papua New Guinea. The term 'kuru' means 'trembling' or 'shivering' in the Fore language, accurately describing a primary symptom of the disease, which also earned it the moniker 'laughing sickness' due to involuntary bursts of laughter.

The transmission of Kuru was directly linked to the Fore people's funerary practice of endocannibalism, where deceased relatives were ritually consumed as a mark of respect and mourning. Women and children were disproportionately affected because they typically consumed the brain, where infectious prions were most concentrated. The epidemic is believed to have originated from a single individual who developed sporadic Creutzfeldt-Jakob disease (CJD), another prion disorder, around the early 1900s, with the disease then spreading through the community via these mortuary feasts. At its peak in the 1950s, the mortality rate in some affected villages reached as high as 35 per 1,000 people.

A key turning point came in the late 1950s when the Australian administration of Papua New Guinea banned cannibalism, a practice that had already begun to decline due to missionary efforts. This cessation of the transmission route led to a dramatic decline in Kuru cases, although new cases continued to emerge for decades due to the disease's exceptionally long incubation period, which could extend to over 50 years. The pioneering research of D. Carleton Gajdusek and Vincent Zigas, beginning in 1957, established the infectious nature of Kuru and its classification as a transmissible spongiform encephalopathy, leading to Gajdusek's Nobel Prize in 1976. Later, Stanley Prusiner's work in 1982 identified prions as the causative agents, earning him a Nobel Prize in 1997, further solidifying Kuru's role in modern neuroscience.

As of 2026, Kuru has virtually disappeared, with the last known death reported in 2009. Despite its eradication, Kuru remains profoundly significant for scientific research. The study of the Fore population revealed a naturally occurring genetic variant (G127V) in the prion protein gene (PRNP) that confers strong resistance to Kuru, demonstrating a powerful example of recent human natural selection. This discovery, published in 2009, continues to inform research into genetic resistance to other prion diseases like CJD and neurodegenerative conditions such as Alzheimer's and Parkinson's. Recent developments include new genetic analyses in March 2024 shedding further light on the epidemic, and research published in April 2025 showing promising results in altering genes to reduce prion protein levels in mice, a potential step towards future treatments. The 'Prion 2025' congress, held in November 2025, further highlighted ongoing advancements in understanding and treating prion diseases, underscoring Kuru's enduring legacy in the field of neurobiology.

What If...?

Explore alternate histories. What if Kuru (disease) made different choices?

Explore Scenarios
Building relationship map...

People Also Ask

What caused Kuru disease?
Kuru was caused by infectious proteins called prions, which were transmitted through the ritualistic practice of endocannibalism among the Fore people of Papua New Guinea. Specifically, consuming the brain tissue of deceased relatives, where prions were concentrated, led to the spread of the disease.
What are the symptoms of Kuru?
Initial symptoms of Kuru include joint pain and headaches, followed by progressive cerebellar ataxia, characterized by tremors, loss of coordination, and an unsteady gait. As the disease progresses, patients experience emotional lability (often including inappropriate laughter), difficulty swallowing, and eventually become bedridden, leading to death typically within one to two years of symptom onset.
Is there a cure for Kuru?
No, there is no known cure or effective treatment for Kuru. Like other prion diseases, it is universally fatal. Treatment focuses solely on supportive care to manage symptoms and improve the patient's quality of life during the progression of the disease.
When was the last case of Kuru reported?
The last known death from Kuru was reported in 2009. While some sources cite the last reported case in 2005, the disease has virtually disappeared since the cessation of endocannibalism in the late 1950s, though its long incubation period meant cases continued to emerge for decades.
How did Kuru contribute to scientific understanding?
Kuru was the first human transmissible spongiform encephalopathy (TSE) to be extensively studied, leading to the discovery of prions as infectious agents. Its study provided crucial insights into the nature of neurodegenerative diseases, the concept of long incubation periods, and human genetic resistance to prion infections, significantly advancing the field of neurobiology.